Dyne Therapeutics, Inc. (DYN) stock

DYNNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30

$17.01−0.98 (-5.45%)

Close on Nov 12, 2026Market cap $3.18BP/E –Yield –

Dyne Therapeutics operating margin

Operating margin is operating income as a percentage of revenue.

Dyne Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?